NHIQ vs. SJ, LUCD, ADEX, PETV, TVGN, TRAW, CHEK, TNXP, IMNN, and NNVC
Should you be buying NantHealth stock or one of its competitors? The main competitors of NantHealth include Scienjoy (SJ), Lucid Diagnostics (LUCD), Adit EdTech Acquisition (ADEX), PetVivo (PETV), Tevogen Bio (TVGN), Traws Pharma (TRAW), Check-Cap (CHEK), Tonix Pharmaceuticals (TNXP), Imunon (IMNN), and NanoViricides (NNVC).
NantHealth (NASDAQ:NHIQ) and Scienjoy (NASDAQ:SJ) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, media sentiment, risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.
Scienjoy has a consensus price target of $91.00, suggesting a potential upside of 11,479.08%. Given Scienjoy's higher possible upside, analysts clearly believe Scienjoy is more favorable than NantHealth.
Scienjoy received 2 more outperform votes than NantHealth when rated by MarketBeat users.
In the previous week, Scienjoy had 5 more articles in the media than NantHealth. MarketBeat recorded 5 mentions for Scienjoy and 0 mentions for NantHealth. NantHealth's average media sentiment score of 0.00 beat Scienjoy's score of -0.25 indicating that NantHealth is being referred to more favorably in the media.
Scienjoy has a net margin of -1.48% compared to NantHealth's net margin of -109.49%. NantHealth's return on equity of 0.00% beat Scienjoy's return on equity.
Scienjoy has higher revenue and earnings than NantHealth.
0.3% of Scienjoy shares are held by institutional investors. 61.3% of NantHealth shares are held by company insiders. Comparatively, 33.6% of Scienjoy shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
NantHealth has a beta of 1.55, indicating that its share price is 55% more volatile than the S&P 500. Comparatively, Scienjoy has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500.
Summary
Scienjoy beats NantHealth on 9 of the 14 factors compared between the two stocks.
Get NantHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for NHIQ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NHIQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
NantHealth Competitors List
Related Companies and Tools
